Loading…
Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis
Therapeutic strategies for leukemia are directed to induction of differentiation and apoptosis as well as growth inhibition. One of the key antileukemic agents, 1-β-D-arabinofuranosylcytosine (ara C), is clinically applied according to these therapeutic aims. However, the molecular effects of 0.1 μg...
Saved in:
Published in: | Molecular and cellular biochemistry 1998-10, Vol.187 (1-2), p.211 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 1-2 |
container_start_page | 211 |
container_title | Molecular and cellular biochemistry |
container_volume | 187 |
creator | Yamada, Hisashi Horiguchi-yamada, Junko Nagai, Makoto Takahara, Shinobu Sekikawa, Tetsuaki Kawano, Takeshi Itoh, Kiyoshi Fukumi, Sachiko Iwase, Satsuki |
description | Therapeutic strategies for leukemia are directed to induction of differentiation and apoptosis as well as growth inhibition. One of the key antileukemic agents, 1-β-D-arabinofuranosylcytosine (ara C), is clinically applied according to these therapeutic aims. However, the molecular effects of 0.1 μg/ml of ara C, a concentration that corresponds to the serum level in leukemic patients on a conventional dose of ara C, have not been well disclosed. Here, we addressed these issues using K562 cells which derived from a blastic crisis of chronic myeloid leukemia. DNA synthesis of treated cells was suppressed from 1-6 h. But, it recovered at 12 h and no further inhibition was observed. The number of cells was not decreased but DNA fragmentation was observed at 72 h. The number of erythroid-differentiated cells also increased to 30% at 72 h. Along with treatment, no marked alteration of mRNAs for cell cycle-regulating genes was found and the retinoblastoma gene product remained hyperphosphorylated throughout treatment. The expression of mRNAs for apoptosis-regulating genes also remained unchanged, except for slight down-regulation of Bax. c-myc protein was not found later than 48 h, and Max mRNA was downregulated. c-jun was immediately induced, followed by the fluctuated expression level along with treatment. These findings suggest that the 0.1 μg/ml ara C changed the proliferation, differentiation and death of K562 cells in a biphasic manner. In the early phase, DNA synthesis was inhibited without altering the expression of cell cycle regulating-genes. In the latter phase, cell death and erythroid- differentiation occurred in accordance with the down-regulation of c-myc.[PUBLICATION ABSTRACT] |
doi_str_mv | 10.1023/A:1006874931249 |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_756250442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2153448891</sourcerecordid><originalsourceid>FETCH-proquest_journals_7562504423</originalsourceid><addsrcrecordid>eNqNjs1OwzAQhC0EEqFw5rriXFM7P03TW6EgJK7cK9fZUFeWN9gOKA_FO-IGHoDTSDPfzixjt1LcS5EXi81aCrFc1WVTyLxszlgmq7rgZSObc5aJQgi-knV9ya5COAqRYCkz9v1gyNK70coCdh3qGIA6UODRqmg-0Y5g6Qs0OY0u-uSROxGS7_mWK6_2xlE3eOUojFaPkYJxCMbBa7XMQaO1YQ0bG_H3dqqPB5wS0KO2OAf0Yzx4Mi1vTXrCpyUz0XNQrgXVU3_qDdfsolM24M2fztjd89Pb4wvvPX0MGOLuSIN3KdrVab0SZZkX_4J-AGYJZuI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>756250442</pqid></control><display><type>article</type><title>Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis</title><source>Springer Nature</source><creator>Yamada, Hisashi ; Horiguchi-yamada, Junko ; Nagai, Makoto ; Takahara, Shinobu ; Sekikawa, Tetsuaki ; Kawano, Takeshi ; Itoh, Kiyoshi ; Fukumi, Sachiko ; Iwase, Satsuki</creator><creatorcontrib>Yamada, Hisashi ; Horiguchi-yamada, Junko ; Nagai, Makoto ; Takahara, Shinobu ; Sekikawa, Tetsuaki ; Kawano, Takeshi ; Itoh, Kiyoshi ; Fukumi, Sachiko ; Iwase, Satsuki</creatorcontrib><description>Therapeutic strategies for leukemia are directed to induction of differentiation and apoptosis as well as growth inhibition. One of the key antileukemic agents, 1-β-D-arabinofuranosylcytosine (ara C), is clinically applied according to these therapeutic aims. However, the molecular effects of 0.1 μg/ml of ara C, a concentration that corresponds to the serum level in leukemic patients on a conventional dose of ara C, have not been well disclosed. Here, we addressed these issues using K562 cells which derived from a blastic crisis of chronic myeloid leukemia. DNA synthesis of treated cells was suppressed from 1-6 h. But, it recovered at 12 h and no further inhibition was observed. The number of cells was not decreased but DNA fragmentation was observed at 72 h. The number of erythroid-differentiated cells also increased to 30% at 72 h. Along with treatment, no marked alteration of mRNAs for cell cycle-regulating genes was found and the retinoblastoma gene product remained hyperphosphorylated throughout treatment. The expression of mRNAs for apoptosis-regulating genes also remained unchanged, except for slight down-regulation of Bax. c-myc protein was not found later than 48 h, and Max mRNA was downregulated. c-jun was immediately induced, followed by the fluctuated expression level along with treatment. These findings suggest that the 0.1 μg/ml ara C changed the proliferation, differentiation and death of K562 cells in a biphasic manner. In the early phase, DNA synthesis was inhibited without altering the expression of cell cycle regulating-genes. In the latter phase, cell death and erythroid- differentiation occurred in accordance with the down-regulation of c-myc.[PUBLICATION ABSTRACT]</description><identifier>ISSN: 0300-8177</identifier><identifier>EISSN: 1573-4919</identifier><identifier>DOI: 10.1023/A:1006874931249</identifier><language>eng</language><publisher>New York: Springer Nature B.V</publisher><subject>Apoptosis ; Biological effects ; Cell cycle ; Deoxyribonucleic acid ; DNA ; Leukemia ; Proteins</subject><ispartof>Molecular and cellular biochemistry, 1998-10, Vol.187 (1-2), p.211</ispartof><rights>Kluwer Academic Publishers 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Yamada, Hisashi</creatorcontrib><creatorcontrib>Horiguchi-yamada, Junko</creatorcontrib><creatorcontrib>Nagai, Makoto</creatorcontrib><creatorcontrib>Takahara, Shinobu</creatorcontrib><creatorcontrib>Sekikawa, Tetsuaki</creatorcontrib><creatorcontrib>Kawano, Takeshi</creatorcontrib><creatorcontrib>Itoh, Kiyoshi</creatorcontrib><creatorcontrib>Fukumi, Sachiko</creatorcontrib><creatorcontrib>Iwase, Satsuki</creatorcontrib><title>Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis</title><title>Molecular and cellular biochemistry</title><description>Therapeutic strategies for leukemia are directed to induction of differentiation and apoptosis as well as growth inhibition. One of the key antileukemic agents, 1-β-D-arabinofuranosylcytosine (ara C), is clinically applied according to these therapeutic aims. However, the molecular effects of 0.1 μg/ml of ara C, a concentration that corresponds to the serum level in leukemic patients on a conventional dose of ara C, have not been well disclosed. Here, we addressed these issues using K562 cells which derived from a blastic crisis of chronic myeloid leukemia. DNA synthesis of treated cells was suppressed from 1-6 h. But, it recovered at 12 h and no further inhibition was observed. The number of cells was not decreased but DNA fragmentation was observed at 72 h. The number of erythroid-differentiated cells also increased to 30% at 72 h. Along with treatment, no marked alteration of mRNAs for cell cycle-regulating genes was found and the retinoblastoma gene product remained hyperphosphorylated throughout treatment. The expression of mRNAs for apoptosis-regulating genes also remained unchanged, except for slight down-regulation of Bax. c-myc protein was not found later than 48 h, and Max mRNA was downregulated. c-jun was immediately induced, followed by the fluctuated expression level along with treatment. These findings suggest that the 0.1 μg/ml ara C changed the proliferation, differentiation and death of K562 cells in a biphasic manner. In the early phase, DNA synthesis was inhibited without altering the expression of cell cycle regulating-genes. In the latter phase, cell death and erythroid- differentiation occurred in accordance with the down-regulation of c-myc.[PUBLICATION ABSTRACT]</description><subject>Apoptosis</subject><subject>Biological effects</subject><subject>Cell cycle</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Leukemia</subject><subject>Proteins</subject><issn>0300-8177</issn><issn>1573-4919</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqNjs1OwzAQhC0EEqFw5rriXFM7P03TW6EgJK7cK9fZUFeWN9gOKA_FO-IGHoDTSDPfzixjt1LcS5EXi81aCrFc1WVTyLxszlgmq7rgZSObc5aJQgi-knV9ya5COAqRYCkz9v1gyNK70coCdh3qGIA6UODRqmg-0Y5g6Qs0OY0u-uSROxGS7_mWK6_2xlE3eOUojFaPkYJxCMbBa7XMQaO1YQ0bG_H3dqqPB5wS0KO2OAf0Yzx4Mi1vTXrCpyUz0XNQrgXVU3_qDdfsolM24M2fztjd89Pb4wvvPX0MGOLuSIN3KdrVab0SZZkX_4J-AGYJZuI</recordid><startdate>19981001</startdate><enddate>19981001</enddate><creator>Yamada, Hisashi</creator><creator>Horiguchi-yamada, Junko</creator><creator>Nagai, Makoto</creator><creator>Takahara, Shinobu</creator><creator>Sekikawa, Tetsuaki</creator><creator>Kawano, Takeshi</creator><creator>Itoh, Kiyoshi</creator><creator>Fukumi, Sachiko</creator><creator>Iwase, Satsuki</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>19981001</creationdate><title>Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis</title><author>Yamada, Hisashi ; Horiguchi-yamada, Junko ; Nagai, Makoto ; Takahara, Shinobu ; Sekikawa, Tetsuaki ; Kawano, Takeshi ; Itoh, Kiyoshi ; Fukumi, Sachiko ; Iwase, Satsuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_7562504423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Apoptosis</topic><topic>Biological effects</topic><topic>Cell cycle</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Leukemia</topic><topic>Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Hisashi</creatorcontrib><creatorcontrib>Horiguchi-yamada, Junko</creatorcontrib><creatorcontrib>Nagai, Makoto</creatorcontrib><creatorcontrib>Takahara, Shinobu</creatorcontrib><creatorcontrib>Sekikawa, Tetsuaki</creatorcontrib><creatorcontrib>Kawano, Takeshi</creatorcontrib><creatorcontrib>Itoh, Kiyoshi</creatorcontrib><creatorcontrib>Fukumi, Sachiko</creatorcontrib><creatorcontrib>Iwase, Satsuki</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Molecular and cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Hisashi</au><au>Horiguchi-yamada, Junko</au><au>Nagai, Makoto</au><au>Takahara, Shinobu</au><au>Sekikawa, Tetsuaki</au><au>Kawano, Takeshi</au><au>Itoh, Kiyoshi</au><au>Fukumi, Sachiko</au><au>Iwase, Satsuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis</atitle><jtitle>Molecular and cellular biochemistry</jtitle><date>1998-10-01</date><risdate>1998</risdate><volume>187</volume><issue>1-2</issue><spage>211</spage><pages>211-</pages><issn>0300-8177</issn><eissn>1573-4919</eissn><abstract>Therapeutic strategies for leukemia are directed to induction of differentiation and apoptosis as well as growth inhibition. One of the key antileukemic agents, 1-β-D-arabinofuranosylcytosine (ara C), is clinically applied according to these therapeutic aims. However, the molecular effects of 0.1 μg/ml of ara C, a concentration that corresponds to the serum level in leukemic patients on a conventional dose of ara C, have not been well disclosed. Here, we addressed these issues using K562 cells which derived from a blastic crisis of chronic myeloid leukemia. DNA synthesis of treated cells was suppressed from 1-6 h. But, it recovered at 12 h and no further inhibition was observed. The number of cells was not decreased but DNA fragmentation was observed at 72 h. The number of erythroid-differentiated cells also increased to 30% at 72 h. Along with treatment, no marked alteration of mRNAs for cell cycle-regulating genes was found and the retinoblastoma gene product remained hyperphosphorylated throughout treatment. The expression of mRNAs for apoptosis-regulating genes also remained unchanged, except for slight down-regulation of Bax. c-myc protein was not found later than 48 h, and Max mRNA was downregulated. c-jun was immediately induced, followed by the fluctuated expression level along with treatment. These findings suggest that the 0.1 μg/ml ara C changed the proliferation, differentiation and death of K562 cells in a biphasic manner. In the early phase, DNA synthesis was inhibited without altering the expression of cell cycle regulating-genes. In the latter phase, cell death and erythroid- differentiation occurred in accordance with the down-regulation of c-myc.[PUBLICATION ABSTRACT]</abstract><cop>New York</cop><pub>Springer Nature B.V</pub><doi>10.1023/A:1006874931249</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-8177 |
ispartof | Molecular and cellular biochemistry, 1998-10, Vol.187 (1-2), p.211 |
issn | 0300-8177 1573-4919 |
language | eng |
recordid | cdi_proquest_journals_756250442 |
source | Springer Nature |
subjects | Apoptosis Biological effects Cell cycle Deoxyribonucleic acid DNA Leukemia Proteins |
title | Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T08%3A01%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biological%20effects%20of%20a%20relatively%20low%20concentration%20of%201-b-D-arabinofuranosylcytosine%20in%20K562%20cells:%20Alterations%20of%20the%20cell%20cycle,%20erythroid-differentiation,%20and%20apoptosis&rft.jtitle=Molecular%20and%20cellular%20biochemistry&rft.au=Yamada,%20Hisashi&rft.date=1998-10-01&rft.volume=187&rft.issue=1-2&rft.spage=211&rft.pages=211-&rft.issn=0300-8177&rft.eissn=1573-4919&rft_id=info:doi/10.1023/A:1006874931249&rft_dat=%3Cproquest%3E2153448891%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_7562504423%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=756250442&rft_id=info:pmid/&rfr_iscdi=true |